Correlation Between Sana Biotechnology and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and InMed Pharmaceuticals, you can compare the effects of market volatilities on Sana Biotechnology and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and InMed Pharmaceuticals.
Diversification Opportunities for Sana Biotechnology and InMed Pharmaceuticals
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sana and InMed is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sana Biotechnology and InMed Pharmaceuticals
Given the investment horizon of 90 days Sana Biotechnology is expected to generate 4.63 times more return on investment than InMed Pharmaceuticals. However, Sana Biotechnology is 4.63 times more volatile than InMed Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 175.00 in Sana Biotechnology on December 24, 2024 and sell it today you would earn a total of 67.00 from holding Sana Biotechnology or generate 38.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sana Biotechnology vs. InMed Pharmaceuticals
Performance |
Timeline |
Sana Biotechnology |
InMed Pharmaceuticals |
Sana Biotechnology and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and InMed Pharmaceuticals
The main advantage of trading using opposite Sana Biotechnology and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |